Gartner Cloud DBMS Report Names MarkLogic a Visionary

Blog

Everything From Data Tips and NoSQL Best Practices to Industry Specific Insights

Without end-to-end visibility into the drug supply chain, how can pharmas make the right decisions on what’s best for patient health and building stronger 1:1 relationships with consumers?
In pharma, where experiment data, research findings, and publications could be highly important in the future, the ability to find the data you need for faster R&D is critical to shortening time to market for new drugs.
In the pharmaceutical industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. In this video, Chief Architect, Imran Chaudhri answers some of the most frequently asked questions about the Pharma Research Hub.
Learn how top pharmaceutical companies are using semantic ontologies to help build a fully interoperable "single source of truth" for their enterprise data.
MarkLogic’s Data Hub provides enterprise-grade security and governance and uses open technologies (e.g., RDF) to enable fully accessible data across the pharma organisation.
The Pharma Research Hub provides easy access to the widest possible array of R&D data available, resolving the main data challenges that curtail R&D processes and drug development.
AbbVie built a MarkLogic-based collaboration suite that enables R&D teams to communicate nimbly with their colleagues throughout the drug discovery and development process.
Drug manufacturers can achieve end-to-end visibility into fragmented supply chains, maintaining efficient control over products—at less time and cost.
This website uses cookies.

By continuing to use this website you are giving consent to cookies being used in accordance with the MarkLogic Privacy Statement.